ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 744449 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 744449; 2) Community: the network communities that were significantly associated with the response to NSC 744449; 3) Molecule: the relationships between components within communities and NSC 744449; 4) MDR: the compounds that were significantly associated with the NSC 744449.

NSC Compound Enrichment Correlation
NSC 87221 Actinomycin D, 2A-D-alloisoleucine- (9CI) 0.0114553853234976 -0.053404721
NSC 89671 Ascotoxin 0.0114553853234976 0.059321253
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0114553853234977 -0.20798336
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0114553853234977 -0.13468302
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.0114553853234977 -0.19015064
NSC 371777 Null 0.0114553853234977 -0.23032353
NSC 614887 Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) 0.0114553853234977 -0.10066808
NSC 63878 Cytarabine Hydrochloride AZ 0.0114553853234977 -0.084855161
NSC 683833 Null 0.0114553853234977 -0.32951978
NSC 684043 1H-Imidazole-4-carboxamide, 5-[[(2-amino-2-carboxyethyl)thio]azo]- 0.0114553853234977 -0.024639199
Total:80  Current:18    [First] [Prev] [Next] [Last]